Article
Leukemia Inhibitory Factor Increases Survival of Pluripotent Stem Cell-Derived Cardiomyocytes.
Journal of cardiovascular translational research - 1 Feb 2018
Blüguermann Carolina, Romorini Leonardo, Evseenko Denis, Garate Ximena, Neiman Gabriel, Sevlever Gustavo Emilio, Scassa María Elida, Miriuka Santiago Gabriel
Abstract excerpt
Leukemia inhibitory factor (LIF) is a growth factor with pleiotropic biological functions. It has been reported that LIF acts at different stages during mesoderm development. Also, it has been shown that LIF has a cytoprotective effect on neonatal murine cardiomyocytes (CMs) in culture, but little is known about the role of LIF during human cardiogenesis. Thus, we analyzed the effects of LIF on human pluripotent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
